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Following the publication of this article \[[@CR1]\], the authors noted the following typographical errors:Affiliation 3 should read "University of Sheffield, Sheffield, United Kingdom" and Affiliations 6, 7, 8 and 9 were unnecessary duplicatesIn the abstract the sentence "Ten patients had mutations in FGA followed by three mutations in FGB and three mutations in FGG, respectively" should be "Ten patients had mutations in *FGA* followed by four mutations in *FGB* and two mutations in *FGG*, respectively."In the Results section the following three sentences:

"In FGA gene, eight mutations were identified as novel and the remaining two were reported mutations. Eight novel mutations include five missense, one nonsense and two frameshift mutations including homozygous and a compound heterozygous frameshift mutation. The two nonsense mutations in FGA are reported in literature. There is one more mutation with reported status in proband (C3). This patient had compound heterozygous mutation with frameshift as novel mutation and nonsense as reported. We identified three mutations in FGB including one novel missense mutation (C9) and two homozygous nonsense mutations reported in siblings. The FGG gene mutations are the rarest of all three fibrinogen genes. We detected three novel mutations including two similar nonsense mutations in siblings and one frameshift mutation in unrelated proband in different exons of FGG gene (Table [1](#Tab1){ref-type="table"})."

Should be:

"In FGA gene, seven mutations were identified as novel and the remaining three were reported mutations. Seven novel mutations include five missense and two frameshift mutations including homozygous and a compound heterozygous frameshift mutation. The three nonsense mutations in FGA are reported in literature. There is one more mutation with reported status in proband (C3). This patient had compound heterozygous mutation with frameshift as novel mutation and nonsense as reported. We identified four mutations in FGB including one novel missense mutation (C9), two homozygous nonsense mutations reported in siblings and one frameshift mutation(C12). The FGG gene mutations are the rarest of all three fibrinogen genes. We detected two novel similar nonsense mutations in siblings (Table [1](#Tab1){ref-type="table"})."4)There are a number of errors in Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}. The corrected versions are provided in this Correction article with the corrections given in bold.5)Frameshift mutation (p.Gln282Thr fsx83\*) and (p. Lys (AAA) 48Arg fs9\*) are the novel compound heterozygous mutations which have manifested deletions along with frameshift defects" should in fact read "Frameshift mutations (p.Thr283Arg fs138\*) and (p. Lys (AAA) 48Arg fs9\*) are the novel compound heterozygous mutations which have manifested deletions along with frameshift defects.

Table 1Genotypic expression of mutations in fibrinogen gene (*FGA, FGB & FGG*)IP \#GeneExonMutationAmino Acid changeZygosityMutation typeReported/NovelC1***FGA***1c.24C \> Ap.Cys8\*HomozygousNonsenseRef \#23 ^€^C22c.143_144 del AAp.Lys (AAA)48Arg fs9\*Compound HeterozygousFrame shiftNovel mutationC35c.846delGp.**Thr 283Arg fs138\***Compound HeterozygousFrame shiftNovel mutation4c.385C \> Tp.Arg129\*HomozygousNonsenseRef \#24 ^€^C44c.385 C \> Tp.Arg129\*HomozygousNonsenseRef \#24 ^€^C55c.598C \> Tp.**Gln200\***HomozygousNonsenseRef 27\*C65c.904C \> Gp.Pro302AlaHomozygousMissenseNovel mutationC75c.913A \> Gp.Thr 305 AlaHomozygousMissenseNovel mutationC85c.992A \> Gp.Thr331AlaHomozygousMissenseNovel mutationC9^**i**^5c.992A \> Gp.Thr331AlaHomozygousMissenseNovel mutationC105**c.973A** \> Gp.Ser325GlyHomozygousMissenseNovel mutationC11A***FGB***2c.141 \> Tp.Arg47\*HomozygousNonsenseRef \# 25 ^€^C11B2c.141C \> Tp.Arg47\*HomozygousNonsenseRef \# 25 ^€^C9 ^**ii**^8c.1294T \> Ap.Trp 432ArgHomozygousMissenseNovel mutation**C122c.118_124dupTTCTTCATTCTTCAHomozygousFrame shiftNovel mutation**C13A***FGG***4c.361A \> Tp.Lys121\*HomozygousNonsenseNovel mutationC13B4c.361A \> TLys121\*HomozygousNonsenseNovel mutationIdentified novel and reported mutations in three genes of fibrinogen. The letter A and B with patient code designate the sibling status, **i & ii shows mutation identified in same patient but in different genes**, € (repor\`ted mutation) c (complimentary deoxyribonucleic acid), A (adenine), T (thymine), C (cytosine), G (guanine), Lys (lysine), Arg (arginine), Tyr (tyrosine), Pro (proline), Trp (tryptophan), Thr (threonine), Gln (glycine), Cys = cystine, fs = frame shift, \* stop codon number, *FGA* (fibrinogen Aα-chain gene), *FGB* (fibrinogen Bβ-chain gene), *FGG* (fibrinogen GƔ-chain gene.

Table 2Assessment of coagulation markers and bleeding scores with consanguinity/ethnicityIP\#Fibrinogen Level\
(g/l)Thrombin Time\
(Sec)Prothrombin Time\
(Sec)Activated partial thromboplastin Time (aPTT) (Sec)Bleeding ScoreConsanguinityInterfamilial RelationEthnic Origin\*C10.0123\> 120\> 18020positiveUnrelatedNAC20.0224\> 120\> 18021positiveUnrelatedPunjabiC3033\> 120\> 18022positiveUnrelatedPunjabiC40.124\> 120\> 18017positiveUnrelatedUrdu SpeakingC50.0231\> 120\> 18020positiveUnrelatedSindhiC60.0125\> 120\> 18020positiveUnrelatedUrdu speakingC70.0229\> 120\> 18022positiveUnrelatedSindhiC80.030\> 120\> 18020positiveUnrelatedSindhiC90.032\> 120\> 18022positiveUnrelatedPunjabiC100.0125\> 120\> 18016positiveUnrelatedPunjabiC11A0.0228\> 120\> 18018positive\*\*PunjabiC11B0.0124\> 120\> 18016positivePunjabiC120.030\> 120\> 18021positiveUnrelatedPunjabiC13A0.0224\> 120\> 18020positive\*\*PunjabiC13B0.0125\> 120\> 18021positivePunjabiShows the individual test values of PT, aPTT and fibrinogen (Clauss Method), consanguinity and the relationship status. Bleeding score calculated, Tosetto et al \[26\]. \*\* Siblings, NA = not available, s (seconds). The fibrinogen levels in all patients were found to be equal to or lower than 0 .1g/l (Normal Range 2-4 g/dl), PT more than 120 s (Normal Range 9--11 s) aPTT more than 180 s (Normal Range 24--27 s) and prolonged thrombin time (normal range 10--13 s). Ethnicity explains the frequency of majorly affected, thickly populated and largest province of Pakistan (Punjab).
